Assessment of the clinical and molecular impact of different cytogenetic subgroups in a series of 272 lipomas with abnormal karyotype

Genes Chromosomes and Cancer

Volumn 46, Issue 6, 2007, Pages 594-606

  Bartuma, Hammurabi ^a   Hallor, Karolin H ^a   Panagopoulos, Ioannis ^a   Collin, Anna ^a   Rydholm, Anders ^a   Gustafson, Pelle ^a   Bauer, Henrik C F ^b   Brosjö, Otte ^b   Domanski, Henryk A ^a   Mandahl, Nils ^a   Mertens, Fredrik ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 10Q; CHROMOSOME 13; CHROMOSOME 6P; CHROMOSOME 8Q; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 12; CLINICAL FEATURE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE DISRUPTION; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HMGA1 GENE; HMGA2 GENE; HUMAN; HUMAN TISSUE; KARYOTYPE; LIPOMA; MAJOR CLINICAL STUDY; MALE; MARKER CHROMOSOME; METAPHASE; MYST4 GENE; NUCLEOTIDE SEQUENCE; PLAG1 GENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RING CHROMOSOME; SUPERNUMERARY CHROMOSOME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 13; COHORT STUDIES; FEMALE; HMGA2 PROTEIN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; INFANT, NEWBORN; KARYOTYPING; LIPOMA; MALE; MIDDLE AGED; NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOFT TISSUE NEOPLASMS;

EID: 34247535802     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20445     Document Type: Article

References (37)

1. Åman P, Ron D, Mandahl N, Fioretos T, Heim S, Arheden K, Willén H, Rydholm A, Mitelman F. 1992. Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11). Genes Chromosomes Cancer 5:278-285.
2. Ashar HR, Schoenberg Fejzo M, Tkachenko A, Zhou X, Fletcher JA, Weremowicz S, Morton CC, Chada K. 1995. Disruption of the architectural factor HMGI-C: dNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 82:57-65.
3. Bassett MD, Schuetze SM, Disteche C, Norwood TH, Swisshelm K, Chen X, Bruckner J, Conrad EU, III, Rubin BP. 2005. Deep-seated, well differentiated lipomatous tumors of the chest wall and extremities. Cancer 103:409-416.
4. Brandal P, Bjerkehagen B, Heim S. 2005. Rearrangement of chromosomal region 8q11-13 in lipomatous tumours: Correlation with lipoblastoma morphology. J Pathol 208:388-394.
5. Broberg K, Zhang M, Strombeck B, Isaksson M, Nilsson M, Mertens F, Mandahl N, Panagopoulos I. 2002. Fusion of RDC1 with HMGA2 in lipomas as the result of chromosome aberrations involving 2q35-37 and 12q13-15. Int J Oncol 21:321-326.
6. Crombez KRMO, Vanoirbeek EMR, Van de Ven WJM, Petit MMR. 2005. Transactivation functions of the tumor-specific HMGA2/ LPP fusion protein are augmented by wild-type HMGA2. Mol Cancer Res 3:63-70.
7. Dahlén A, Debiec-Rychter M, Pedeutour F, Domanski HA, Höglund M, Bauer HCF, Rydholm A, Sciot R, Mandahl N, Mertens F. 2003a. Clustering of deletions on chromosome 13 in benign and low-malignant lipomatous tumors. Int J Cancer 103:616-623.
8. Dahlén A, Mertens F, Rydholm A, Brosjö O, Wejde J, Mandahl N, Panagopoulos I. 2003b. Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas. Mod Pathol 16:1132-1140.
9. Dei Tos AP, Pedeutour F. 2002. Atypical lipomatous tumour/well differentiated liposarcoma, In: Fletcher CDM, Unni KK, Mertens F, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press, pp. 35-37.
10. Fletcher CDM, Åkerman M, Dal Cin P, de Wever I, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, van den Berghe H, van de Ven W, Vanni R, Willén H. 1996. Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the chromosomes and morphology (CHAMP) collaborative study group. Am J Pathol 148:623-630.
11. Fletcher CDM, Unni KK, Mertens F. 2002. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press, 427 p.
12. Hallor KH, Mertens F, Jin Y, Meis-Kindblom JM, Kindblom L-G, Behrendtz M, Kalén A, Mandahl N, Panagopoulos I. 2005. Fusion of the EWSR1 and ATFI genes without expression of the MITF-M transcript in angiomatoid fibrous histiocytoma. Genes Chromosomes Cancer 44:97-102.
13. Hauke S, Leopold S, Schlueter C, Flohr AM, Escobar HM, Rogalla P, Bullerdiek J. 2005. Extensive expression studies revealed a complex alternative splicing pattern of the HMGA2 gene. Biochim Biophys Acta 1729:24-31.
14. Heim S, Mandahl N, Kristoffersson U, Mitelman F, Rööser B, Rydholm A, Willén H. 1986. Reciprocal translocation t(3;12)(q27;q13) in lipoma. Cancer Genet Cytogenet 23:301-304.
15. Heim S, Mandahl N, Kristoffersson U, Mitelman F, Rööser B, Rydholm A, Willén H. 1987. Marker ring chromosome - A new cytogenetic abnormality characterizing lipogenic tumors? Cancer Genet Cytogenet 24:319-326.
16. Hibbard MK, Kozakewich HP, Dal Cin P, Sciot R, Tan X, Xiao S, Fletcher JA. 2000. PLAG1 fusion oncogenes in lipoblastoma. Cancer Res 60:4869-4872.
17. ISCN. 1995. An International System for Human Cytogenetics Nomenclature 1995. Mitelman F, editor. Basel: Karger. 114 p.
18. Kazmierczak B, Dal Cin P, Wanschura S, Borrmann L, Fusco A, Van den Berghe H, Bullerdiek J. 1998. HMGIY is the target of 6p21.3 rearrangements in various benign mesenchymal tumors. Genes Chromosomes Cancer 23:279-285.
19. Kazmierczak B, Meyer-Bolte K, Tran KH, Wöckel W, Breightman I, Rosigkeit J, Bartnitzke S, Bullerdiek J. 1999. A high frequency of tumors with rearrangements of genes of the HMGI(Y) family in a series of 191 pulmonary chondroid hamartomas. Genes Chromosomes Cancer 26:125-133.
20. Ligon AH, Moore SDP, Parisi MA, Mealiffe ME, Harris DJ, Ferguson HL, Quade BJ, Morton CC. 2005. Constitutional rearrangement of the architectural factor HMGA2: A novel human phenotype including overgrowth and lipomas. Am J Hum Genet 76:340-348.
21. Mandahl N, Heim S, Johansson B, Bennet K, Mertens F, Olsson G, Rööser B, Rydholm A, Willén H, Mitelman F. 1987. Lipomas have characteristic structural chromosomal rearrangements of 12q13-14. Int J Cancer 39:685-688.
22. Mandahl N, Heim S, Arheden K, Rydholm A, Willén H, Mitelman F. 1988. Three major cytogenetic subgroups can be identified among chromosomally abnormal solitary lipomas. Hum Genet 79:203-208.
23. Mandahl N, Heim S, Arheden K, Rydholm A, Willén H, Mitelman F. 1990. Chromosomal rearrangements in chondromatous tumors. Cancer 65:242-248.
24. Mandahl N, Höglund M, Mertens F, Rydholm A, Willén H, Brosjö O, Mitelman F. 1994. Cytogenetic aberrations in 188 benign and borderline adipose tissue tumors. Genes Chromosomes Cancer 3:207-215.
25. Mandahl N, Åkerman M, Åman P, Dal Cin P, De Wever, I, Fletcher CDM, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, Van Den Berghe H, Van de Ven W, Vanni R, Willén H. 1996. Duplication of chromosome segment 12q15-24 is associated with atypical lipomatous tumors: A report of the CHAMP collaborative study group. Int J Cancer 67:632-635.
26. Mertens F, Rydholm A, Brosjö O, Willén H, Mitelman F, Mandahl N. 1994. Hibernomas are characterized by rearrangements of chromosome bands 11q13-21. Int J Cancer 58:503-505.
27. Mertens F, Johansson B, Höglund M, Mitelman F. 1997. Chromosomal imbalance maps of malignant solid tumors: A cytogenetic survey of 3185 neoplasms. Cancer Res 57:2765-2780.
28. Mitelman Database of Chromosome Aberrations in Cancer. 2006. Mitelman F, Johansson B, Mertens F (editors). http://cgap.nci.nih.gov/Chromosomes/Mitelman
29. Moore SDP, Herrick SR, Ince TA, Kleinman MS, Dal Cin P, Morton CC, Quade BJ. 2004. Uterine leiomyomata with t(10;17) disrupt the histone acetyltransferase MORF. Cancer Res 64:5570-5577.
30. Nielsen GP, Mandahl N. 2002. Lipoma, In: Fletcher CDM, Unni KK, Mertens F, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press, pp. 20-22.
31. Rydholm A, Berg NO. 1983. Size, site and clinical incidence of lipoma. Factors in the differential diagnosis of lipoma and sarcoma. Acta Orthop Scand 54:929-934.
32. Schoenmakers EFPM, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, Van de Ven WJM. 1995. Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat Genet 10:436-444.
33. Sreekantaiah C, Leong SPL, Karakousis CP, McGee DL, Rappaport WD, Villar HV, Neal D, Fleming S, Wankel A, Herrington PN, Carmona R, Sandberg AA. 1991. Cytogenetic profile of 109 lipomas. Cancer Res 51:422-433.
34. Turc-Carel C, Dal Cin P, Rao U, Karakousis C, Sandberg AA. 1986. Cytogenetic studies of adipose tissue tumors. I. A benign lipoma with reciprocal translocation t(3;12)(q28;q14). Cancer Genet Cytogenet 23:283-289.
35. Weiss SW, Goldblum JR. 2001. Soft Tissue Tumors, 4th ed. New York: Mosby, pp 571-639.
36. Willén H, Åkerman M, Dal Cin P, De Wever I, Fletcher CDM, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, Van Den Berghe H, Vanni R. 1998. Comparison of chromosomal patterns with clinical features in 165 lipomas: A report of the CHAMP study group. Cancer Genet Cytogenet 102: 46-49.
37. Zaidi MR, Okada Y, Chada KK. 2006. Misexpression of full-length HMGA2 induces benign mesenchymal tumors in mice. Cancer Res 66:7453-7459.